57
Table 37. ACCF/AHA/AMA-PCPI 2011 HF Measurement Set
(continued)
Measure Description
a
Care
Setting
Level of
Measurement
• Beta-blocker
therapy
for LVSD
(outpatient
and inpatient
setting )
Percentage of patients aged ≥18 y
with a diagnosis of HF with a current
or prior LVEF <40% who were
prescribed beta-blocker therapy with
bisoprolol, carvedilol, or sustained-
release metoprolol succinate either
within a 12-mo period when seen in
the outpatient setting or at hospital
discharge
Inpatient
and
outpatient
• Individual
practitioner
• Facility
• ACE
inhibitor or
ARB therapy
for LVSD
(outpatient
and inpatient
setting )
Percentage of patients aged ≥18 y
with a diagnosis of HF with a current
or prior LVEF <40% who were
prescribed ACE inhibitor or ARB
therapy either within a 12-mo period
when seen in the outpatient setting
or at hospital discharge
Inpatient
and
outpatient
• Individual
practitioner
• Facility
• Counseling
about ICD
implantation
for patients
with
LVSD on
combination
medical
therapy
b,c
Percentage of patients aged ≥18 y
with a diagnosis of HF with current
LVEF ≤35% despite ACE inhibitor/
ARB and beta-blocker therapy for at
least 3 mo who were counseled about
ICD implantation as a treatment
option for the prophylaxis of sudden
death
Outpatient • Individual
practitioner
• Postdischarge
appointment
for HF
patients
Percentage of patients, regardless of
age, discharged from an inpatient
facility to ambulatory care or home
health care with a principal discharge
diagnosis of HF for whom a follow-
up appointment was scheduled and
documented including location, date
and time for a follow-up office visit,
or home health visit (as specified)
Inpatient • Facility
a
Refer to the complete measures for comprehensive information, including measure exception.
b
Test measure designated for use in internal quality improvement programs only. ese measures
are not appropriate for any other purpose (eg, pay for performance, physician ranking, or public
reporting programs).
c
New measure.
Adapted from Bonow RO, et al. Circulation. 2012;125:2382-2401.
